U.S., Dec. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07301632) titled 'Ecstasy to Alleviate SEvere Chronic Neuropathic Pain Trial' on Nov. 17.
Brief Summary: This is a Health Canada regulated internal pilot study designed to assess the feasibility, tolerability, and preliminary efficacy of 3, 4-methylenedioxymethamphetamine hydrochloride capsules-AT for chronic neuropathic pain to inform a larger, fully powered multi-center study. This is an interventional, randomized, 2-arm parallel, triple blinded study.
The total study duration is 2 years.
Participants will receive preparatory psychotherapy session during week 2 and week 4 followed by a combined single dosing session with psychotherapy during week...